CYTOKINETICS INC — Director's Dealing 2021

Apr 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-04-09

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-09	Common Stock	M	3207	$6.82	Acquired	4127	Direct
2021-04-09	Common Stock	S	3207	$24.0	Disposed	920	Direct
2021-04-09	Common Stock	M	5000	$7.61	Acquired	5920	Direct
2021-04-09	Common Stock	S	5000	$23.7896	Disposed	920	Direct
2021-04-09	Common Stock	M	5000	$7.61	Acquired	5920	Direct
2021-04-09	Common Stock	S	5000	$23.7989	Disposed	920	Direct
2021-04-09	Common Stock	M	5000	$7.61	Acquired	5920	Direct
2021-04-09	Common Stock	S	5000	$23.7885	Disposed	920	Direct
2021-04-09	Common Stock	M	5000	$7.61	Acquired	5920	Direct
2021-04-09	Common Stock	S	5000	$23.7899	Disposed	920	Direct
2021-04-09	Common Stock	M	4375	$10.0	Acquired	5295	Direct
2021-04-09	Common Stock	S	4375	$24.5	Disposed	920	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-09	Non-Qualified Stock Option (right to buy)	$6.82	M	3207	Disposed	2029-01-02	Common Stock (3207)	Direct
2021-04-09	Non-Qualified Stock Option (right to buy)	$7.61	M	5000	Disposed	2026-05-18	Common Stock (5000)	Direct
2021-04-09	Non-Qualified Stock Option (right to buy)	$7.61	M	5000	Disposed	2026-05-18	Common Stock (5000)	Direct
2021-04-09	Non-Qualified Stock Option (right to buy)	$7.61	M	5000	Disposed	2026-05-18	Common Stock (5000)	Direct
2021-04-09	Non-Qualified Stock Option (right to buy)	$7.61	M	5000	Disposed	2026-05-18	Common Stock (5000)	Direct
2021-04-09	Non-Qualified Stock Option (right to buy)	$10.0	M	4375	Disposed	2026-01-04	Common Stock (4375)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021.

F2: Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.